Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Major Depressive Disorder”

745 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 745 results

Testing effectiveness (Phase 2)Study completedNCT06259526
What this trial is testing

The Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression

Who this might be right for
Depression
Tasly Pharmaceutical Group Co., Ltd 267
Not applicableUnknownNCT05210153
What this trial is testing

Personalized Sertraline Dosing in Patients With Depression

Who this might be right for
Depressive Disorder, Major
University of Belgrade 148
Post-approval studies (Phase 4)Looking for participantsNCT07136714
What this trial is testing

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Who this might be right for
Major Depressive Disorder
Nordsjaellands Hospital 116
Testing effectiveness (Phase 2)Study completedNCT01413932
What this trial is testing

Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder

Who this might be right for
Healthy Volunteers (Part 1)Major Depressive Disorder (Part 2)
Dart NeuroScience, LLC 26
Not applicableStudy completedNCT04342299
What this trial is testing

The Antidepressant Advisor (Study 3): fMRI Study to Predict Treatment Response in Patients With Depression

Who this might be right for
Major Depressive Disorder
King's College London 45
Not applicableStudy completedNCT04598906
What this trial is testing

Ecologically Valid Virtual Tasks vs Paper-pencil Methods in Cognitive Rehabilitation in Patients With Schizophrenia and Depression

Who this might be right for
SchizophreniaDepressionCognitive Impairment
National Institute of Mental Health, Czech Republic 35
Testing effectiveness (Phase 2)Study completedNCT03899285
What this trial is testing

Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders

Who this might be right for
Major Depressive Disorder
Ciusss de L'Est de l'Île de Montréal 8
Not applicableStudy completedNCT00149110
What this trial is testing

Chronos: the Use of Chronobiological Treatment in Depression

Who this might be right for
Major Depression
Hillerod Hospital, Denmark 75
Large-scale testing (Phase 3)Study completedNCT01034462
What this trial is testing

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Forest Laboratories 442
Early research (Phase 1)Looking for participantsNCT06920238
What this trial is testing

Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use

Who this might be right for
Cannabis Use DisorderAnxietyDepression, Anxiety+1 more
Trustees of Dartmouth College 15
Testing effectiveness (Phase 2)Ended earlyNCT01554176
What this trial is testing

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022)

Who this might be right for
Major Depressive Disorder, Recurrent
Merck Sharp & Dohme LLC 129
Large-scale testing (Phase 3)Study completedNCT02709746
What this trial is testing

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

Who this might be right for
Depressive Disorder, Major
H. Lundbeck A/S 784
Not applicableStudy completedNCT04891224
What this trial is testing

Use of a Digitally Enabled App With Clinical Team Interface in the Management of Depression

Who this might be right for
Major Depressive Disorder
Wake Forest University Health Sciences 89
Large-scale testing (Phase 3)Study completedNCT01428661
What this trial is testing

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Vanda Pharmaceuticals 507
Not applicableStudy completedNCT01479920
What this trial is testing

A Positron Emission Topographic (PET) Study on Depression Patient With Electroacupuncture

Who this might be right for
Major Depressive DisorderDepression
The University of Hong Kong 36
Testing effectiveness (Phase 2)Study completedNCT01369095
What this trial is testing

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Who this might be right for
Depression
Bristol-Myers Squibb 976
Post-approval studies (Phase 4)Study completedNCT00785434
What this trial is testing

Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD

Who this might be right for
Major Depressive Disorder
Community Pharmacology Services Ltd 60
Testing effectiveness (Phase 2)Study completedNCT01020799
What this trial is testing

AZD7268 Safety and Tolerability Study

Who this might be right for
Major Depressive Disorder
AstraZeneca 247
Testing effectiveness (Phase 2)Ended earlyNCT01957410
What this trial is testing

Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Janssen Research & Development, LLC 13
Large-scale testing (Phase 3)Study completedNCT00320268
What this trial is testing

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca 600
Load More Results